Kalaycioglu, E. Et Al. 2014. Osteoprotegerin Is Associated With Subclinical Left Ventricular Systolic Dysfunction in Diabetic Hypertensive Patients: A Speckle Tracking Study. CANADIAN JOURNAL OF CARDIOLOGY , vol.30, no.12 , 1529-1534.

Kalaycioglu, E., Gokdeniz, T., Aykan, A. C., Hatem, E., Gursoy, M. O., Oren, A., ... YAMAN, H.(2014). Osteoprotegerin Is Associated With Subclinical Left Ventricular Systolic Dysfunction in Diabetic Hypertensive Patients: A Speckle Tracking Study. CANADIAN JOURNAL OF CARDIOLOGY , vol.30, no.12, 1529-1534.

Kalaycioglu, Ezgi Et Al. "Osteoprotegerin Is Associated With Subclinical Left Ventricular Systolic Dysfunction in Diabetic Hypertensive Patients: A Speckle Tracking Study," CANADIAN JOURNAL OF CARDIOLOGY , vol.30, no.12, 1529-1534, 2014

Kalaycioglu, Ezgi Et Al. "Osteoprotegerin Is Associated With Subclinical Left Ventricular Systolic Dysfunction in Diabetic Hypertensive Patients: A Speckle Tracking Study." CANADIAN JOURNAL OF CARDIOLOGY , vol.30, no.12, pp.1529-1534, 2014

Kalaycioglu, E. Et Al. (2014) . "Osteoprotegerin Is Associated With Subclinical Left Ventricular Systolic Dysfunction in Diabetic Hypertensive Patients: A Speckle Tracking Study." CANADIAN JOURNAL OF CARDIOLOGY , vol.30, no.12, pp.1529-1534.

@article{article, author={Ezgi Kalaycioglu Et Al. }, title={Osteoprotegerin Is Associated With Subclinical Left Ventricular Systolic Dysfunction in Diabetic Hypertensive Patients: A Speckle Tracking Study}, journal={CANADIAN JOURNAL OF CARDIOLOGY}, year=2014, pages={1529-1534} }